Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Coltman

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Cancer Treatment Reports|December 1, 1986
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group StudyR B Livingston, S Schulman, J G Mira, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemiaM R Grever, K J Kopecky, C A Coltman, et al.
Cancer Investigation|January 11, 1991
Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology GroupL Dabich, S Dahlberg, R J Hartsock, et al.
Leukemia|July 1, 1992
Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenanceF S Morrison, K J Kopecky, D R Head, et al.
Blood|November 1, 1982
The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology GroupB N Nathwani, D O Dixon, S E Jones, et al.
Cancer|April 15, 1983
Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group StudyS E Jones, A Haut, J K Weick, et al.
Cancer|August 1, 1971
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphomaJ K Luce, J F Gamble, H E Wilson, et al.
Cancer|April 1, 1993
American Cancer Society Workshop on Adolescents and Young Adults with Cancer. Workgroup #1: Long-term care and lifetime follow-upW A Bleyer, R A Smith, D M Green, et al.
Annals of Internal Medicine|June 1, 1994
Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized studyC J Fabian, C M Mansfield, S Dahlberg, et al.
Annals of Internal Medicine|April 1, 1988
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trialR I Fisher, C A Coltman, J H Doroshow, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Cancer Treatment Reports|December 1, 1986
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group StudyR B Livingston, S Schulman, J G Mira, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemiaM R Grever, K J Kopecky, C A Coltman, et al.
Cancer Investigation|January 11, 1991
Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology GroupL Dabich, S Dahlberg, R J Hartsock, et al.
Leukemia|July 1, 1992
Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenanceF S Morrison, K J Kopecky, D R Head, et al.
Blood|November 1, 1982
The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology GroupB N Nathwani, D O Dixon, S E Jones, et al.
Cancer|April 15, 1983
Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group StudyS E Jones, A Haut, J K Weick, et al.
Cancer|August 1, 1971
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphomaJ K Luce, J F Gamble, H E Wilson, et al.
Cancer|April 1, 1993
American Cancer Society Workshop on Adolescents and Young Adults with Cancer. Workgroup #1: Long-term care and lifetime follow-upW A Bleyer, R A Smith, D M Green, et al.
Annals of Internal Medicine|June 1, 1994
Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized studyC J Fabian, C M Mansfield, S Dahlberg, et al.
Annals of Internal Medicine|April 1, 1988
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trialR I Fisher, C A Coltman, J H Doroshow, et al.
Pageof 17